Pacific Biosciences of California, Inc. (PACB)
2.11
+0.05
(+2.43%)
USD |
NASDAQ |
Oct 23, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Enterprise Value : 1.125B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.125B |
| October 22, 2026 | 1.109B |
| October 21, 2026 | 1.134B |
| October 20, 2026 | 1.078B |
| October 19, 2026 | 1.041B |
| October 16, 2026 | 1.007B |
| October 15, 2026 | 1.078B |
| October 14, 2026 | 1.088B |
| October 13, 2026 | 1.106B |
| October 12, 2026 | 1.122B |
| October 09, 2026 | 1.193B |
| October 08, 2026 | 1.184B |
| October 07, 2026 | 1.315B |
| October 06, 2026 | 1.308B |
| October 05, 2026 | 1.361B |
| October 02, 2026 | 1.259B |
| October 01, 2026 | 1.249B |
| September 30, 2026 | 1.206B |
| September 29, 2026 | 1.038B |
| September 28, 2026 | 1.001B |
| September 25, 2026 | 972.73M |
| September 24, 2026 | 960.30M |
| September 23, 2026 | 907.46M |
| September 22, 2026 | 926.11M |
| September 21, 2026 | 891.92M |
| Date | Value |
|---|---|
| September 18, 2026 | 895.03M |
| September 17, 2026 | 898.14M |
| September 16, 2026 | 885.71M |
| September 15, 2026 | 885.71M |
| September 14, 2026 | 888.81M |
| September 11, 2026 | 873.27M |
| September 10, 2026 | 863.95M |
| September 09, 2026 | 870.17M |
| September 08, 2026 | 879.49M |
| September 04, 2026 | 888.81M |
| September 03, 2026 | 873.27M |
| September 02, 2026 | 879.49M |
| September 01, 2026 | 867.06M |
| August 31, 2026 | 890.37M |
| August 28, 2026 | 904.36M |
| August 27, 2026 | 950.98M |
| August 26, 2026 | 954.08M |
| August 25, 2026 | 941.65M |
| August 24, 2026 | 867.06M |
| August 21, 2026 | 888.81M |
| August 20, 2026 | 851.52M |
| August 19, 2026 | 863.95M |
| August 18, 2026 | 823.54M |
| August 17, 2026 | 845.30M |
| August 14, 2026 | 826.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 42.04B |
| Danaher Corp. | 184.25B |
| Thermo Fisher Scientific, Inc. | 284.58B |
| Agilent Technologies, Inc. | 50.99B |
| Bio-Rad Laboratories, Inc. | 9.642B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.74M |
| Revenue (Quarterly) | 39.01M |
| Total Expenses (Quarterly) | 83.75M |
| EPS Diluted (Quarterly) | -0.144 |
| Gross Profit Margin (Quarterly) | 30.26% |
| Profit Margin (Quarterly) | -114.7% |
| Earnings Yield | -20.43% |
| Normalized Earnings Yield | -18.60 |